JP Patent

JP6503317B2 — Ｃ−ｍｅｔ調節剤の薬学的組成物

Assigned to エクセリクシス， インク． · Expires 2019-04-17 · 7y expired

What this patent protects

Patent listed against cabozantinib-s-malate.

Drugs covered by this patent

Patent Metadata

Patent number
JP6503317B2
Jurisdiction
JP
Classification
—
Expires
2019-04-17
Drug substance claim
No
Drug product claim
No
Assignee
エクセリクシス， インク．
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.